agilon health (NYSE:AGL) Stock Price Up 7.4% – Here’s Why

agilon health, inc. (NYSE:AGL) shares traded up 7.4% during mid-day trading on Monday . The company traded as high as $2.79 and last traded at $2.77. 654,664 shares changed hands during trading, a decline of 87% from the average session volume of 4,907,535 shares. The stock had previously closed at $2.58.

Analyst Ratings Changes

AGL has been the topic of a number of recent research reports. Benchmark reissued a “buy” rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Evercore ISI dropped their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft cut their price target on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $8.03.

agilon health Price Performance

The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The company’s fifty day moving average price is $3.62 and its 200 day moving average price is $5.14. The firm has a market capitalization of $1.09 billion, a price-to-earnings ratio of -3.93 and a beta of 0.54.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.07). The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. agilon health’s revenue was up 38.7% on a year-over-year basis. During the same quarter last year, the company posted ($0.04) earnings per share. Equities research analysts expect that agilon health, inc. will post -0.32 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On agilon health

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its holdings in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after buying an additional 371,537 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC increased its holdings in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares during the period. Capital International Investors raised its stake in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. Finally, Simplicity Wealth LLC raised its stake in shares of agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after purchasing an additional 15,515 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.